Quantcast

Latest Ribomed Biotechnologies Inc. Stories

2013-12-05 23:31:06

RiboMed Biotechnologies, Inc. and NuvOx Pharma today jointly announced that they have entered into a collaborative agreement that will utilize RiboMed’s epigenetic biomarker test, GliomaSTRAT™, to characterize tumors from brain cancer patients and correlate response to NuvOx’s new drug, NVX-108 in the treatment of Glioblastoma multiforme (GBM). Carlsbad, CA and Tucson, AZ (PRWEB) December 05, 2013 RiboMed Biotechnologies, Inc. and NuvOx Pharma today jointly announced that they have...

2013-06-13 23:27:32

RiboMed Biotechnologies, Inc. (http://www.ribomed.com), a company that develops epigenetic-based tests that provide improved cancer diagnosis and allow drug therapy to be personalized for the benefit of cancer patients, today announced that it has partnered with researchers at the Austrian Institute of Technology (AIT, Vienna) to commercialize their clinically validated lung cancer DNA methylation biomarkers. Lung cancer is the number-one cause of cancer deaths in both men and women in the...

2012-12-06 05:02:37

RiboMed Biotechnologies Inc., a leading Epigenetics-Based Diagnostics company, today announced that the U.S. Patent and Trademark Office has issued three additional patents covering the use of their core technology, Abscription® (Abortive Transcription), for disease and biowarfare agent related biomarker detection. The patents expand protection to MethylMagnet® and MethylMeter®, RiboMed´s bisulfite-free DNA methylation detection products and assays, including a new prognostic...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related